What Is It?
This combination pairs CJC-1295 without the drug affinity complex (DAC) — a short-acting analog of growth-hormone-releasing hormone — with ipamorelin, a selective ghrelin-receptor agonist. Together, they act on two complementary pathways to stimulate pulsatile release of the body's own growth hormone. This product is compounded in the United States and is not FDA-approved. Some providers use it as part of a broader plan intended to support body composition, sleep, and recovery in eligible adults, always under monitoring. It is not a substitute for FDA-approved growth-hormone therapy. Note: the long-acting CJC-1295 with DAC version is not offered by VidaVital Medical.
What May It Support?
- Body composition support
- Lean-mass preservation during medical weight management
- Sleep quality (being evaluated)
- Recovery (being evaluated)
Which Programs May Include It?
Where It Fits
CJC-1295 (no DAC) stimulates pituitary GHRH receptors while ipamorelin binds ghrelin (GHS-R1a) receptors; together, they may amplify pulsatile growth-hormone release without meaningfully raising cortisol or prolactin.
Do I Need Bloodwork?
Regular follow-up with periodic IGF-1 and metabolic labs at intervals determined by the provider.
Likely baseline panel may include: CBC, CMP, A1c, Lipid panel, IGF-1, TSH, Free T4, Pregnancy test when applicable
Important Safety Information
Common side effects may include:
- Injection-site reactions
- Flushing
- Headache
- Light-headedness
- Vivid dreams
- Increased appetite (from ipamorelin's ghrelin activity)
- Water retention
May contribute to fluid retention or joint discomfort
May affect glucose metabolism
Should not be combined with other growth-hormone secretagogues by default
Drug interactions: May interact with corticosteroids, thyroid hormone, insulin, and medications that affect glucose metabolism. Provider should review the complete medication list before prescribing.
Contraindications:
- Active malignancy
- Disruption of the hypothalamic-pituitary axis
- Pregnancy or breastfeeding
- Known hypersensitivity to either component
Regulatory Status
This combination is not FDA-approved. It is dispensed in the United States only as a compounded prescription.
Frequently Asked Questions
Is this growth hormone?
Why not the long-acting version with DAC?
Do I need bloodwork before starting?
Can I stack this with another growth-hormone therapy?
Consultation
Treatment is not automatically provided. A licensed medical provider must review your history, symptoms, medications, laboratory results, and treatment goals before determining eligibility.